Table 2.

Comparison between baseline and end of study in both groups.

Parameter	Control group			Intervention group
	Baseline	At end of study	p-value	Baseline	At end of study	p-value
Serum creatinine (mg/dL), mean ± SD	1.69 ± 0.5	1.66 ± 0.5	0.33†	1.78 ± 0.6	1.75 ± 0.9	0.02†
eGFR (ml/min/1.73 m2), mean ± SD	38.6 ± 11.4	39.9 ± 14.1	0.24†	37.8 ± 11.2	41.6 ± 15	0.01*
Blood urea (mg/dL), mean ± SD	76 ± 25	74 ± 22	0.74*	81 ± 32	77 ± 39	0.04†
Triglycerides (mg/dL), mean ± SD	210 ± 100	203 ± 77	0.48†	183 ± 83	221 ± 95	< 0.01†
LDL-cholesterol (mg/dL), mean ± SD	92 ± 24	84 ± 26	0.08†	85 ± 28	83 ± 33	0.45†
HDL-cholesterol (mg/dL), mean ± SD	39 ± 14	36 ± 11	0.30*	42 ± 14	40 ± 11	0.03†
Blood glucose (mg/dL), mean ± SD	129 ± 57	141 ± 78	0.77†	132 ± 62	146 ± 68	0.01†
CPK (U/L), mean ± SD	139 ± 147	73 ± 47	0.03†	108 ± 73	137 ± 240	0.01†

HDL high density lipoprotein, LDL low density lipoprotein, eGFR estimated glomerular filtration rate, CPK creatine kinase.

*Paired sample t-test.

^†Wilcoxon.